EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets

Barbara Licznerska iD, Hanna Szaefer iD, Hanna Sobierajska iD, Wanda Baer-Dubowska iD

International Journal of Molecular Sciences · 30.07.2026 · 27 (15) · 6823

DOI: 10.3390/ijms27156823 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2026. Verfasst von Barbara Licznerska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, 60-806 Poznań, Poland. Hauptthemen laut MEDLINE: Receptors, Estrogen, Estrogens, Breast Neoplasms. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogens, particularly the most active 17β-estradiol (E2), play a crucial role in the initiation and development of breast cancer. Therefore, current treatment strategies are based on interfering with estrogen receptors (ERs) via pure antiestrogens or selective modulators (SERMs) or by inhibiting estrogen synthesis through key enzymes in this pathway. While SERMs are generally effective, resistance often develops. Moreover, they cannot be used to treat triple-negative breast cancers (TNBCs). Three critical enzymes in the estrogen synthesis pathway, namely aromatase, sulfatase, and 17β-hydroxysteroid dehydrogenases, are of particular interest as drug targets. Some, such as aromatase inhibitors, are already used in clinical practice, while the other two remain under intensive investigation. Several comprehensive reviews have been published on ER modulators or individual enzyme inhibitors. This paper attempts to summarize recent data on modulators/inhibitors of both the ER and the major enzymes involved in estrogen biosynthesis and offers a perspective on their further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, EstrogenEstrogensBreast NeoplasmsHumansFemale17-Hydroxysteroid DehydrogenasesAromataseAnimalsAromatase InhibitorsMolecular Targeted Therapy

Stichwörter der Autor:innen

17β-hydroxysteroid dehydrogenasesaromatasebreast cancerestrogen receptorssteroid sulfatase

Substanzen

Receptors, EstrogenEstrogens17-Hydroxysteroid DehydrogenasesAromataseAromatase Inhibitors

Autor:innen und Institutionen

  • Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, 60-806 Poznań, Poland.

ORCID-Profile: Barbara Licznerska, Hanna Szaefer, Hanna Sobierajska, Wanda Baer-Dubowska

Zitieren

APA

Licznerska, B., Szaefer, H., Sobierajska, H., & Baer-Dubowska, W. (2026). Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets. International Journal of Molecular Sciences, 27(15), 6823. https://doi.org/10.3390/ijms27156823

Vancouver

Licznerska B, Szaefer H, Sobierajska H, Baer-Dubowska W. Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets. International Journal of Molecular Sciences. 2026;27(15):6823. doi:10.3390/ijms27156823

BibTeX
@article{Licznerska2026,
  author = {Licznerska, Barbara and Szaefer, Hanna and Sobierajska, Hanna and Baer-Dubowska, Wanda},
  title = {Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6823},
  doi = {10.3390/ijms27156823}
}
Kostenlos starten →